The newest episode of Lung Cancer Considered, the IASLC's official podcast program, is a Spanish language podcast focusing on the use of telemedecine during this time and how lung cancer patients can find information in different regions of the world. This episode features a conversation between Dr. Narjust Duma, assistant professor of medicine, thoracic oncologist at the University of Wisconsin; Dr. José Corona-Cruz, thoracic surgical oncologist at the Instituto Nacional de Cancerología in México; and Dr. Antonio Calles, medical oncologist in the Division of Medical Oncology at the Hospital General Universitario Gregorio Marañón in Madrid, Spain.

The newest episode of Lung Cancer Considered, the IASLC's official podcast program, focuses on a collection of journal articles and guidelines about COVID-19 in patients with lung cancer. This episode features a conversation between IASLC Chief Science Officer, Dr. Chandra Belani and Dr. Erin Bange, oncology fellow of the University of Pennsylvania School of Medicine.

The newest episode of Lung Cancer Considered, the IASLC's official podcast program, focuses on the recent Journal of Thoracic Oncology study, "Potential Impact of Cessation Interventions at the Point of Lung Cancer Screening on Lung Cancer and Overall Mortality in the United States." This episode features a conversation between Dr. Jack West and Dr. Rafael Meza, associate professor in the department of epidemiology and co-leader of the cancer epidemiology and prevention program at the University of Michigan Rogel Cancer Center.

This episode features Dr. Shu-Yuan Xiao, professor of pathology at the University of Chicago and Lung Cancer Considered host Dr. Jack West discussing a COVID-19 report that was recently published in the Journal of Thoracic Oncology. The study covers the pathology of two COVID-19 positive patients from Wuhan who were originally treated for lung cancer.

This episode features Janet Freeman- Daily, writer, lung cancer patient, advocate and Twitter chat moderator of the Lung Cancer Social Media chat (#LCSMchat), she is joined by Dr. Amy Moore, Director of Science and Research at the Go2 Foundation, Dr. Upal Basu Roy, Vice President of Research at LUNGevity Foundation, and Dr. Lecia Sequist, Director of Center for Innovation and Early Cancer Detection at Massachusetts General Hospital and the Landry Family Associate Professor of Medicine at Harvard Medical School. Together they discuss the impact of the COVID-19 epidemic on lung cancer patients and healthcare providers.

This episode features a conversation between Dr. Marty Edelman, Chair of the Department of Hematology/Oncology and a Professor, Department of Hematology/Oncology at Fox Chase Cancer Center and IASLC President, Dr. Tetsuya Mitsudomi, a Professor at the Division of Thoracic Surgery, Department of Surgery at Kindai University Faculty of Medicine in Osaka-Sayama, Japan. Together they discuss highlights of Dr. Mitsudomi's career, his goals as President of IASLC and what his hopes are for the future of lung cancer research.

This episode features Dr. Marty Edelman, Chair of the Department of Hematology/Oncology and a Professor, Department of Hematology/Oncology at Fox Chase Cancer Center. He is joined by Dr. Roy Herbst, a Professor of Medicine and Pharmacology, Chief of Medical Oncology, and Associate Director for Translational Research at Yale Cancer Center/ Yale School of Medicine; and Dr. Leora Horn, the Ingram Associate Professor of Cancer Research at Vanderbilt Ingram Cancer Center and Clinical Director, Thoracic Oncology Program. Together they discuss highlights from the 20th IASLC 2020 Lung Cancer Targeted Therapies conference in Santa Monica

This episode features Janet Freeman- Daily, writer, lung cancer patient, advocate and Twitter chat moderator of the Lung Cancer Social Media chat (#LCSMchat), she is joined by Dr. Paul Bunn, a distinguished professor and Dudley Endowed Chair at the University of Colorado Comprehensive Cancer Center and IASLC Past President and Past CEO; as well as Dr. Suresh Ramalingam, Roberto Goizueta Chair in Cancer Research, Winship Cancer Institute of Emory University. Together they discuss the upcoming IASLC 2020 Lung Cancer Targeted Therapies meeting in Santa Monica.

This episode features a conversation between Dr. Heather Wakelee, Professor of Medicine in the Division of Oncology at Stanford University and faculty director of the Stanford Cancer Clinical Trials Office and current president-elect of the IASLC and Dr. Chandra Belani, professor of Medicine in the Division of Hematology/Oncology in the Department of Medicine at the Penn State Hershey Medical Center in Hershey, Penn. The interview covers Dr. Belani’s new position as chief science officer for the IASLC and the history of his involvement with lung cancer.

This episode features a conversation between Dr. Heather Wakelee, professor of Medicine in the Division of Oncology at Stanford University and faculty director of the Stanford Cancer Clinical Trials Office and current president-elect of the IASLC and Dr. Chandra Belani, professor of Medicine in the Division of Hematology/Oncology at the Penn State Hershey Medical Center in Hershey, Penn., and the chief science officer for the IASLC. Together they discuss a recent study from the American Cancer Society that reported a significant drop in the cancer mortality rate, led largely by progress in lung cancer.